Please assess the completion status of the following clinical trial:

Trial Title: A Study to Evaluate Efficacy of YM060 on Diarrhea-predominant Irritable Bowel Syndrome (D-IBS) in Female Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Patients meeting the Rome III Diagnostic Criteria~* Loose (mushy) or watery stools within the last 3 months~* Abdominal discomfort and/or pain during their non-menstrual period~Exclusion Criteria:~* Patients with a history of surgical resection of the stomach, small intestine or large intestine~* Patients with a history or current diagnosis of inflammatory bowel disease (Crohn's disease or colitis ulcerative)~* Patients with a history or current diagnosis of colitis ischemic~* Patients with a current diagnosis of enteritis infectious~* Patients with a current diagnosis of hyperthyroidism or hypothyroidism~* Patients who are currently participating in another clinical trial (including a post-marketing clinical study) or those who participated in another clinical trial (including a post-marketing clinical study) within 12 weeks before the study~* Patients with a history or current diagnosis of malignant tumor~* Patients with a history of abuse of drugs or alcohol within 1 year or those who are currently abusing them

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Study Arms:
- placebo group (Type: PLACEBO_COMPARATOR): None
- YM060 low-dose group (Type: EXPERIMENTAL): None
- YM060 middle-dose group (Type: EXPERIMENTAL): None
- YM060 high-dose group (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).